Biogen ditches Aduhelm, Alzheimer's drug that was approved amid controversy

byHywo Published:January 31, 2024

Biogen will give up ownership and halt sales of Aduhuelm, an Alzheimer's disease drug that was met with skepticism and scrutiny following its 2021 approval.

from USA TODAY - Breaking News and Latest News Today https://ift.tt/zj8bwrn
via IFTTT

Tags: IFTTT USA TODAY - Breaking News and Latest News Today

Biogen ditches Aduhelm, Alzheimer's drug that was approved amid controversy

Shahid Kapoor’s wife Mira Rajput reveals about almost suffering from miscarriage in her first pregnancy; says, “I almost miscarried when I was four months pregnant”

Karan Johar reveals the reason behind giving Koffee With Karan a skip in 2024; calls Season 8 rapid fire a ‘snooze alert’

The duster coat: a timeless symbol of style and functionality

Ameesha Patel reacts to fan suggestion to marry Salman Khan: “Salman is not married, and nor, am….”

Isha Ambani pays tribute to Gujarati Heritage in breathtaking Bandhani saree at Radhika Merchant mameru ceremony

Categories

Biogen ditches Aduhelm, Alzheimer's drug that was approved amid controversy

You might like